期刊文献+

B/T淋巴细胞弱化因子在急性哮喘小鼠模型CD4^+ T淋巴细胞表达的研究

Expression of BTLA in CD4^+ T lymphocytes of acute asthma mice model
暂未订购
导出
摘要 目的研究负向共刺激受体B/T淋巴细胞弱化因子(B and T lymphocyte attenuator,BTLA)在急性哮喘小鼠模型脾脏CD4+T淋巴细胞中的表达特点及地塞米松对BTLA表达的影响。方法 18只BALB/C6小鼠按随机数字表法分为空白对照组、哮喘模型组、地塞米松治疗组。OVA联合AL(OH)3第1和第8天分别致敏和第15~17天激发,建立急性哮喘模型。HE染色观察3组气道炎症浸润情况;Elisa检测血清IL-4和IFN-γ;流式细胞术检测小鼠脾脏CD4+T淋巴细胞BTLA表达变化。结果 HE染色哮喘组肺部小气道和血管周围炎症细胞浸润(EOS)明显,上皮细胞增生;流式细胞仪检测哮喘组脾脏CD4+T淋巴细胞表面BTLA表达较对照组明显增高(P<0.01),BTLA在地塞米松治疗组比哮喘模型组和空白对照组均增高,差异有统计学意义(P<0.05)。结论 BTLA在急性哮喘模型表达上调参与炎症调控;地塞米松能进一步上调BTLA表达,抑制气道炎症。 Objective To investigate the expression of B and T lymphocyte attenuator (BTLA) in CIM+ T lymphocytes of a mouse acute asthma model and the influence of DXM on the expression. Methods Mice were sensitized by intraperitoneal injection of OVA and aluminium in saline and challenged by nebulization of 2. 5% OVA on days 15 - 17. HE stating was performed to examine air-way inflammation of control, asthma and DXM groups. Serum concentrations of IL-4 and IFN-γ were assayed by ELISA kits. Expression of BTLA in the membrane of CD4+lymphocytes of mice was analyzed by flow cytometry. Results Prominent perivascular and peribronchial eosinophilic inflammatory cell infiltration, along with subepithelia goblet cell hyperplasia, was observed in the asthma mice. The highest expression of BTLA in the membrane of CD4+T lymphocytes was observed by flow cytometry in the DXM group, followed by the asthma group, and the lowest in the control group ( P 〈 0. 05 ). Conclusion Expression of BTLA is increased in acute asthma mice model, and could be further up-regulated by DXM.
出处 《实用医院临床杂志》 2013年第4期15-18,共4页 Practical Journal of Clinical Medicine
基金 国家自然科学基金面上项目资助(编号:81170025)
关键词 哮喘 B T淋巴细胞弱化因子 CD4+T细胞 地塞米松 Asthma B and T lymphocyte attenuator CD4+T cell Dexamethasone
  • 相关文献

参考文献16

  • 1Gould H J, Sutton B J, Beavil AJ, et al. The biology of IGE and the ba- sis of allergic disease [ J]. Annu Rev Immunol,2003,21:579-628.
  • 2Stem DA, Riedler J, Nowak D, et al. Exposure to a fanning environ- ment has allergen-specific protective effects on TH2-dependent iso- type switching in response to common inhalants [ J ]. J Allergy Clin Immunol,2007,119(2) : 351-358.
  • 3Zhu Y,Yao S,Chen L. Cell surface signaling molecules in the control of immune responses: a tide model [J]. Immunity,2011,34(4) : 466-478.
  • 4Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited [J]. Annu Rev Immunol,2005 ,23 :515-548.
  • 5Burton p R, Clayton DG, Cardon L, et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls [ J ]. Nature,2007,447 (7145 ) : 661-678.
  • 6Wing K, Onishi Y, Prieto-martin P, et al. CTLA-4 control over Foxp3 + regulatory T cell function [ J ]. Science, 2008,322 ( 5899 ) : 271 - 275.
  • 7Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of vi- res-specific CD8+ T cell survival in HIV infection [ J]. J Exp Med, 2006,203 (10) : 2281-2292.
  • 8Yee I_J, Perez KA, Tang J, et al. Association of CTLA4 polymor- phisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection [ J ]. J Infect Dis, 2003,187 ( 8 ) : 1264-1271.
  • 9Deppong C, Juehne TI, Hurchla M, et al. Cutting edge : B and T lym- phocyte attenuator and programmed death receptor-1 inhibitory re- ceptors are required for termination of acute allergic airway inflamma- tion [ J ]. J Immunol,2006,176 (7) : 3909-3913.
  • 10Locke Nit, Royce SG, Wainewright JS, et al. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease [ J]. Am J Ilespir Cell Mol Biol,2007,36(5) : 625-632.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部